Association of selective serotonin reuptake inhibitors with the risk of type 2 diabetes in children and adolescents
In some embodiments, the mobile phase D further includes an aqueous solution of an ammonium salt in an amount of from 20% to 60%, 30% to 60%, 40% to 60%, or about 50% by volume
Iron, vitamin B12, or folate supplements may be prescribed to address deficiencies
Results In findings from the phase 3 SURMOUNT-1 trial (NCT04184622), the percentage of patients who lost more than 20% of their body weight was over 50% in the tirzepatide 10-mg and 15-mg groups, compared with just 3% in the placebo group
The American journal of clinical nutrition , 94 (3), 847853